We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SCBFY:OTCStandard Chartered PLC Analysis

Data as of 2026-03-11 - not real-time

$45.56

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Standard Chartered PLC trades just above a clear technical support level while the 20‑day SMA sits below the current price, suggesting limited downside room. Momentum indicators are mixed: the MACD has turned bearish, volume is trending lower, and the RSI sits in the low‑mid range, hinting at a modest oversold condition. Volatility remains elevated and beta is close to market, underscoring price swings that could be amplified by broader market moves. The stock offers an attractive dividend yield relative to peers and a price‑to‑earnings multiple that is comfortably below the industry average, pointing to a valuation gap with an estimated upside of roughly 15‑20%.
Fundamentally, revenue growth is modest but steady, and operating margins are healthy, supporting the earnings outlook. A low payout ratio combined with a substantial cash buffer mitigates concerns from the recent negative operating cash flow. The bank’s diversified geographic footprint spreads risk, though regulatory scrutiny in multiple jurisdictions remains a factor. Overall, the combination of value‑oriented pricing, solid fundamentals, and dividend appeal makes the stock a candidate for accumulation, especially for investors comfortable with short‑term volatility.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near technical support
  • Bearish MACD and decreasing volume
  • Elevated short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued relative to industry PE
  • Attractive dividend yield with low payout ratio
  • Potential upside of 15‑20% based on target price

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Stable earnings margins and modest revenue growth
  • Strong cash reserves offsetting cash‑flow concerns
  • Diversified geographic exposure reducing concentration risk

Key Metrics & Analysis

Financial Health

Revenue Growth2.30%
Profit Margin25.09%
P/E Ratio12.0
ROE9.63%
ROA0.58%
P/B Ratio2.3
Op. Cash Flow$-34529001472
Industry P/E17.3

Technical Analysis

TrendNeutral
RSI38.9
Support$42.89
Resistance$50.88
MA 20$48.19
MA 50$49.63
MA 200$41.12
MACDBearish
VolumeDecreasing
Fear & Greed Index76.25

Valuation

Target Price$53.60
Upside/Downside17.65%
GradeUndervalued
TypeValue
Dividend Yield2.69%

Risk Assessment

Beta0.96
Volatility40.34%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.